Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Deltacel by Kiromic BioPharma for Non-Small Cell Lung Cancer: Likelihood of Approval
Deltacel is under clinical development by Kiromic BioPharma and currently in Phase I for Non-Small Cell Lung Cancer. According to...
Data Insights
Deltacel by Kiromic BioPharma for Squamous Cell Carcinoma: Likelihood of Approval
Deltacel is under clinical development by Kiromic BioPharma and currently in Phase I for Squamous Cell Carcinoma. According to GlobalData,...